Company intelligence / Profile preview

Nora Therapeutics, Inc.

Palo Alto, California, United Statesnoratherapeutics.com ↗
Ownership
Private
Employees
~8
Development stage
Other
01

Overview

Nora Therapeutics was a privately-held biotechnology company focused on developing novel therapeutics for reproductive medicine, specifically targeting infertility due to failed IVF cycles and recurrent pregnancy loss. Its lead compound, NT100—a biologic similar to naturally occurring proteins in the female reproductive tract—was designed to optimize maternal-fetal immune tolerance. The company advanced NT100 into two main Phase 2 clinical trials (THRIVE-IVF for failed IVF cycles and RESPONSE for unexplained recurrent pregnancy loss). No commercial products were launched before the company became inactive around or after March 2018. Clinical results have not been published in detail.

Therapeutic areas
Women's Health
Modalities
Biologic agent (proprietary G-CSF/granulocyte-colony stimulating factor)synthetic peptide
Industry
Biotech
02

Drug pipeline

1 asset

NT100

2
03

Partnerships

Investors included Novo A/S/Novo Ventures, Burrill & Company, Prospect Venture Partners, Rho Ventures, Vivo Capital

Beyond the preview

Go deeper on Nora Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nora Therapeutics, Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call